Neha Life Science Profile
Key Indicators
- Authorised Capital ₹ 7.10 M
- Paid Up Capital ₹ 7.10 M
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
- Revenue Growth 44.35%
- Profit Growth 6.73%
- Ebitda 7.79%
- Net Worth 332.63%
- Total Assets 48.48%
About Neha Life Science
Neha Life Science Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 July 2002 and has a history of 22 years and six months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Harsh Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.10 M and a paid-up capital of Rs 7.10 M.
The company currently has active open charges totaling ₹4.00 Cr.
Hemanginiben Gandhi and Neha Gandhi serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2002PTC041016
-
Company No.
041016
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jul 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Neha Life Science Private Limited offer?
Neha Life Science Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Neha Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemanginiben Gandhi
|
Director | 24-Feb-2008 | Current |
|
Neha Gandhi
|
Director | 12-Sep-2019 | Current |
Financial Performance of Neha Life Science.
Neha Life Science Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 44.35% increase. The company also saw a slight improvement in profitability, with a 6.73% increase in profit. The company's net worth Soared by an impressive increase of 332.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neha Life Science?
In 2021, Neha Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2021 | Sidbi | ₹2.00 Cr | Open |
| 04 Aug 2021 | Sidbi | ₹2.00 Cr | Open |
How Many Employees Work at Neha Life Science?
Unlock and access historical data on people associated with Neha Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neha Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neha Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
